2019
DOI: 10.1002/jac5.1135
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacy driven assessment of appropriate antibiotic selection in patients with reported beta‐lactam allergy

Abstract: Background Reported beta‐lactam (BL) antibiotic allergies lead to the avoidance of BL antibiotics. Despite that less than 10% of patients reporting have a true allergy, the documentation often leads to an increased use of alternative antibiotics. These nonpreferred antibiotics (NPA) have a significant impact on cost, clinical outcomes, and antimicrobial resistance. Objective The primary objective of this study was to assess the impact of a pharmacy‐driven assessment on the prescribing frequency of penicillin o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 22 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…Upon notification, the pharmacy staff performed an allergy assessment, which included a review of previous beta-lactam tolerance, and clarification of the reaction type, severity, and timing of the allergy. The pharmacist allergy assessment resulted in increased frequency of beta-lactam prescribing in patients with previously reported beta-lactam allergy, by 12.9%, and a decrease in the days of therapy of non-penicillin antibiotic use, by 123 days of therapy per 1000 patient days, again showing the benefit of pharmacist involvement in penicillin allergy assessment [29].…”
Section: Low Risk Of Allergymentioning
confidence: 83%
“…Upon notification, the pharmacy staff performed an allergy assessment, which included a review of previous beta-lactam tolerance, and clarification of the reaction type, severity, and timing of the allergy. The pharmacist allergy assessment resulted in increased frequency of beta-lactam prescribing in patients with previously reported beta-lactam allergy, by 12.9%, and a decrease in the days of therapy of non-penicillin antibiotic use, by 123 days of therapy per 1000 patient days, again showing the benefit of pharmacist involvement in penicillin allergy assessment [29].…”
Section: Low Risk Of Allergymentioning
confidence: 83%